Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
8 min read
EXTL2 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXTL2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXTL1 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXTL1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXT2 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXT2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXT1 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXT1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXPH5 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXPH5, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXOSC10 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOSC10, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXOSC9 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOSC9, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXOSC8 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOSC8, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXOSC7 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOSC7, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXOSC6 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOSC6, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXOSC5 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOSC5, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXOSC4 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOSC4, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.